Deciphera Pharmaceuticals

Home » Deciphera Pharmaceuticals

IPO

Deciphera Pharmaceuticals

They are a clinical-stage biopharmaceutical company developing new drugs to improve the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response of many cancer therapies.

Symbol

DCPH

Price Range
$15.00 - $17.00

Anticipated Shares
7,000,000

Anticipated Date
TBD

Underwriters
J.P. Morgan, Piper Jaffray

To view the prospectus for Deciphera Pharmaceuticals IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253